SCHEMBL1335772

SCHEMBL1335772

[c]1c(-c2ccccc2)cc2ccc3cccc4ccc1c2c43

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
HSD17B10 Q99714 4/20 0.39
CYP1A2 P05177 3/20 0.39
HPGD P15428 3/20 0.39
TSHR P16473 3/20 0.39
CYP1A1 P04798 2/20 0.39
CYP1B1 Q16678 2/20 0.39
CYP3A4 P08684 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ERBB2 P04626 1/20 0.39
FYN P06241 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
AHR P35869 1/20 0.39
KDM4E B2RXH2 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
THRB P10828 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2453887 0.89 CYP1A2 (0.42) ALDH1A1HSD17B10CYP1A2HPGDTSHR
SCHEMBL7706251 0.86 GSTP1 (0.38) CYP1A2TSHRMEN1KMT2AERBB2
SCHEMBL5965308 0.85 CYP1A2 (0.40) ALDH1A1HSD17B10CYP1A2HPGDTSHR
SCHEMBL5742402 0.77 CYP1A2 (0.46) ALDH1A1HSD17B10CYP1A2HPGDTSHR
SCHEMBL18317718 0.76 MEN1 (0.37) ALDH1A1HSD17B10CYP1A2HPGDTSHR
SCHEMBL18317658 0.76 RAB9A (0.39) ALDH1A1HSD17B10CYP1A2HPGDTSHR
SCHEMBL18317417 0.76 KDM4E (0.42) ALDH1A1HSD17B10CYP1A2HPGDTSHR
SCHEMBL18317390 0.72 CYP1A2 (0.38) ALDH1A1HSD17B10CYP1A2HPGDCYP3A4
SCHEMBL3462089 0.72 ALDH1A1 (0.55) ALDH1A1HSD17B10CYP1A2HPGDTSHR
SCHEMBL6418835 0.72 ALDH1A1 (0.44) ALDH1A1HSD17B10CYP1A2HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024135665-A1 POLYIMIDE COMPOUND, NEGATIVE ELECTRODE MATERIAL FOR LITHIUM ION SECONDARY BATTERIES THAT USES SAID POLYIMIDE COMPOUND, NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERIES, AND LITHIUM ION SECONDARY BATTERY ウィンゴーテクノロジー株式会社 2024-06-27 WO disclosed
CN-118176259-A Dispersion of carbon nanotubes, coating liquid composition for electrode using same, electrode, and lithium ion secondary battery 第一工业制药株式会社 2024-06-11 CN disclosed
CN-113795938-B Organic light-emitting element, laminate, and light-emitting method 九州有机光材股份有限公司 2024-05-28 CN disclosed
EP-4318676-A1 POLYIMIDE COMPOUND, NEGATIVE ELECTRODE MATERIAL FOR LITHIUM ION SECONDARY BATTERIES THAT USES SAID POLYIMIDE COMPOUND, NEGATIVE ELECTRODE FOR LITHIUM ION SECONDARY BATTERIES, AND LITHIUM ION SECONDARY BATTERY Wingo Technology Co., Ltd. (JP) 2024-02-07 EP disclosed
US-20230146030-A1 ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-05-11 US disclosed
WO-2023080059-A1 DISPERSION OF CARBON NANOTUBES, COATING LIQUID COMPOSITION FOR ELECTRODE USING SAME, ELECTRODE, AND LITHIUM ION SECONDARY BATTERY 第一工業製薬株式会社 2023-05-11 WO disclosed
US-20220162445-A1 POLYIMIDE COMPOUND AND MOLDED ARTICLE COMPRISING THE POLYIMIDE COMPOUND WINGO TECHNOLOGY CO., LTD. (JP) 2022-05-26 US disclosed
CN-112110825-B Arylamine compound, electronic element using arylamine compound and electronic device 陕西莱特光电材料股份有限公司 2022-02-11 CN disclosed
EP-3919548-A1 POLYIMIDE COMPOUND AND MOLDED ARTICLE CONTAINING SAID POLYIMIDE COMPOUND Wingo Technology Co., Ltd. (JP) 2021-12-08 EP disclosed
WO-2021213109-A1 ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE 陕西莱特光电材料股份有限公司 (CN) 2021-10-28 WO disclosed
US-20090167156-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2009-07-02 US disclosed
US-20090015144-A1 FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND SOLUTION CONTAINING ORGANIC ELECTROLUMINESCENCE MATERIAL IDEMITSU KOSAN CO., LTD. (JP) 2009-01-15 US disclosed
EP-2008992-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2008-12-31 EP disclosed
EP-1990844-A1 ORGANIC ELECTROLUMINESCENT DEVICE Idemitsu Kosan Co., Ltd. (JP) 2008-11-12 EP disclosed
US-20080004445-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-01-03 US disclosed
US-20070243411-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2007-10-18 US disclosed
US-5382687-A Electrography HITACHI CHEMICAL COMPANY LTD. (JP) 1995-01-17 US disclosed
EP-0448389-B1 Enamine derivatives and their use in electrophotographic member HITACHI CHEMICAL CO LTD (JP) 1994-12-14 EP disclosed
US-5272030-A Electrophotographic member comprising enamine derivatives HITACHI CHEMICAL COMPANY, LTD. (JP) 1993-12-21 US disclosed
EP-0448389-A1 Enamine derivatives and their use in electrophotographic member Hitachi Chemical Co., Ltd. (JP) 1991-09-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230146030-A1 ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE OCIAD2, AOC2, OCIAD1 ALDH1A1 442/4885HSD17B10 1096/4885CYP1A2 60/4885
US-20080004445-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME TYR, MAOA, PRDM9 ALDH1A1 291/4885HSD17B10 3259/4885CYP1A2 507/4885
US-20090015144-A1 FLUORANTHENE COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND SOLUTION CONTAINING ORGANIC ELECTROLUMINESCENCE MATERIAL LEF1, ESD, AFF2 ALDH1A1 422/4885HSD17B10 2452/4885CYP1A2 927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.